Finance

Lists
4503:TYO
Astellas Pharma Inc
၂,၂၈၉.၀၀ JP¥
+၁.၈၅%
(+၄၁.၅၀) 1D
အောက် ၁၃, GMT+၉ ၁၂:၃၄:၅၇  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4503...
Open
၂,၂၈၈ JP¥
High
၂,၂၉၀ JP¥
Low
၂,၂၅၁ JP¥
Mkt. cap
ဋေ ၄.၁၄ သိန်း
Avg. vol.
၆.၀၁ သန်း
Volume
၁.၆၀ သန်း
Dividend
၃.၄၁%
Quarterly dividend
၂၀ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၁.၂၄
52-wk high
၂,၇၁၇ JP¥
52-wk low
၁,၅၅၈ JP¥
EPS
၂၀၄ JP¥
Shares outstanding
၁၉၂.၀၈ ဋေ
No. of employees
၁ သောင်း
Open
၂,၂၈၈ JP¥
High
၂,၂၉၀ JP¥
Low
၂,၂၅၁ JP¥
Mkt. cap
ဋေ ၄.၁၄ သိန်း
Avg. vol.
၆.၀၁ သန်း
Volume
၁.၆၀ သန်း
Dividend
၃.၄၁%
Quarterly dividend
၂၀ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၁.၂၄
52-wk high
၂,၇၁၇ JP¥
52-wk low
၁,၅၅၈ JP¥
EPS
၂၀၄ JP¥
Shares outstanding
၁၉၂.၀၈ ဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
What Does VEON (NASDAQ:VEON) Satellite To Mobile Launch Mean For Bangladesh?
BeInCrypto
BeInCrypto
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
Citi Says S&P 500 Needs AI and Non-AI Stocks to Reach 8,100
HDFC Sky
HDFC Sky
·
ပြီးခဲ့သည့် ၄၃ မိနစ်
Dow Rises 196 Points; Oil Surge Hits Tech Stocks
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees၁.၄၁ သောင်း
Founded၂၀၀၅ ဧ ၁
HeadquartersChuo City, တိုကျိုမြို့, ဂျပန်
Sector-
Last report
၂၀၂၆ ဩ ၅
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
ဋေ ၆.၄၁ သ / ဋေ ၅.၆၂ သ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၅.၂၄ သ
ဋေ ၅.၅၅ သ
ဋေ ၅.၃၈ သ
ဋေ ၆.၄၁ သ
Cost of goods sold
ဋေ ၁.၀၆ သ
ဋေ ၁.၀၄ သ
ဋေ ၉.၃၇ ထ
ဋေ ၁.၂၃ သ
Cost of revenue
ဋေ ၁.၀၆ သ
ဋေ ၁.၀၄ သ
ဋေ ၉.၃၇ ထ
ဋေ ၁.၂၃ သ
Research and development expenses
ဋေ ၇.၁၆ ထ
ဋေ ၈.၅၈ ထ
ဋေ ၉.၅၉ ထ
ဋေ ၈.၁၇ ထ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၀၇ သ
ဋေ ၂.၂၈ သ
ဋေ ၂.၃၅ သ
ဋေ ၂.၁၅ သ
Operating expense
ဋေ ၃.၂၆ သ
ဋေ ၃.၅၉ သ
ဋေ ၃.၃၆ သ
ဋေ ၃.၃၃ သ
Total operating expenses
ဋေ ၄.၃၁ သ
ဋေ ၄.၆၃ သ
ဋေ ၄.၃၀ သ
ဋေ ၄.၅၆ သ
Operating income
ဋေ ၉.၂၉ ထ
ဋေ ၉.၁၆ ထ
ဋေ ၁.၀၈ သ
ဋေ ၁.၈၅ သ
Other non operating income
-
၁.၅၀ သန်း
-၂၄.၁၀ ကုဋေ
၁.၀၀ သန်း
EBT including unusual items
ဋေ ၁.၀၄ သ
ဋေ ၉.၁၀ ထ
ဋေ ၄.၈၀ ထ
ဋေ ၁.၈၇ သ
EBT excluding unusual items
ဋေ ၉.၂၄ ထ
ဋေ ၉.၀၈ ထ
ဋေ ၁.၁၄ သ
ဋေ ၁.၈၇ သ
Income tax expense
ဋေ ၂.၅၀ ထ
ဋေ ၁.၉၀ ထ
၄၄၀.၈၀ ဋေ
ဋေ ၄.၄၈ ထ
Effective tax rate
၂၃.၉၇%
၂၀.၉၀%
၉.၁၈%
၂၄.၀၀%
Other operating expenses
ဋေ ၁.၄၇ ထ
၉၇၂.၃၅ ဋေ
-ဋေ ၂.၉၉ ထ
၃၈.၈၀ ကုဋေ
Net income
ဋေ ၇.၉၂ ထ
ဋေ ၇.၂၀ ထ
ဋေ ၄.၃၅ ထ
ဋေ ၁.၄၂ သ
Net profit margin
၁၅.၁၁%
၁၂.၉၇%
၈.၀၉%
၂၂.၁၃%
Earnings per share
-
-
-
-
Interest and investment income
၂၁၅.၂၀ ဋေ
၂၁၀.၃၅ ဋေ
၁၂၉.၀၀ ဋေ
၅၁၃.၀၀ ဋေ
Interest expense
-၂၆၉.၃၀ ဋေ
-၂၇၄.၀၅ ဋေ
-
-၃၁၂.၁၀ ဋေ
Net interest expenses
-၅၄.၁၀ ကုဋေ
-၆၃.၇၀ ကုဋေ
၁၂၉.၀၀ ဋေ
၂၀၀.၉၀ ဋေ
Depreciation and amortization charges
-ဋေ ၃.၂၈ ထ
-
ဋေ ၃.၅၈ ထ
-
EBITDA
ဋေ ၁.၄၀ သ
ဋေ ၁.၄၁ သ
ဋေ ၁.၅၈ သ
ဋေ ၂.၃၅ သ
Gain or loss from assets sale
ဋေ ၁.၆၄ ထ
-
ဋေ ၃.၁၅ ထ
-
AI content may include mistakes. Learn more
Google အက်ပ်များ